Navigation Links
Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C
Date:8/19/2009

otease inhibitor compound RG7227/ ITMN-191 in Phase 2b, a second-generation HCV protease inhibitor research program, and a research program evaluating new targets in hepatology. For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated product development timelines. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.

Factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in InterMune's most recent annual report on Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to the long, expensive and uncertain clinical development and regulatory process, including having no unexpected safety, toxicology, clinical or other issues or delays in anticipated timing of the regulatory approval process; (ii) risks related to failure to achieve the clinical trial results required to commercialize our product candidates; and (iii) risks related to timely patient enrollment and retention in clinical trials. The risks and other factors disc
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Rochester Medical Reports Third Quarter Results
2. Roche Cardiac 200 Offers Rapid Cardiac Diagnostics for the Point of Care
3. Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009
4. Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
5. Roche Diabetes Care Announces Unique Coaching Program for Diabetes Educators as Part of Long-Term Commitment to Fight the Disease
6. NJLRA Statement in Response to Roches Discontinuation of Accutane(R)
7. Orochem Technologies Acquires Oligonet, a Custom Oligo Synthesis Business
8. Purple Communications Dream Bigger Initiative Honors Rochester Physician and Deaf Community Trailblazer
9. Rochester Medical Corporation Set to Join Russell 3000 Index
10. Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
11. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... should significantly reform the federal system for financing ... the public,s $15 billion annual investment is producing ... new report by the Institute of Medicine. ... requires little accountability, allocates funds independent of workforce ... to train physicians in the health care settings ...
(Date:7/29/2014)... July 29, 2014 Frank Davis, Activz ... can help parents add nutrition to their kids’ meals ... – Key market drivers in kids’ foods market” by ... pleased to announce the interview Frank Davis had with ... Activz organic vegetable and fruit produce powders to kids ...
(Date:7/29/2014)... health institutions, including Penn State College of Medicine, ... and expand a health data research network., The ... through the Patient Protection and Affordable Care Act, ... Pittsburgh, Temple University and Johns Hopkins University -- ... four universities have come together to create a ...
(Date:7/29/2014)... According to a new report series ... authority in medical device market research, the Global ... $8 billion by 2018. This growth will be ... heart valve market, which is comprised of both the ... valve repair (TMVR) segments. , There are many risks ...
(Date:7/29/2014)... the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) and the ... improve access to essential pain medications for people living ... Treat the Pain initiative, this new partnership will help ... services throughout the country. , Swaziland has the ... 26 percent of adults ages 15-49 infected. Many of ...
Breaking Medicine News(10 mins):Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 2Health News:Activz Organic Fruit and Vegetable Produce Powders and Founder Frank Davis Mentioned in WholeFoods Magazine Article 3Health News:New network unites university health care research 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 2Health News:Global Transcatheter Heart Valve Devices Market Outlook to 2018: Breakthrough Developments led by Abbott, Edwards LifeSciences and Medtronic 3Health News:New partnership to improve access to essential pain medications for people living with HIV 2
... quality of life, study finds , , SATURDAY, March ... tea and acupuncture, may safely and effectively help ... Use of Erka Shizheng Herbal Tea, a bath ... the severity of the itchy, red skin condition and ...
... MINNEAPOLIS, March 13 HealthFitness Corporation (NYSE ... health and productivity management solutions, announced today that Gregg ... Winnekins, chief financial officer, will present at the B. ... Conference on Thursday, March 19, 2009 at 11:00 a.m. ...
... Cardiovascular Institute achieves milestone outcomes for heart transplantCHICAGO, ... United Network of Organ Sharing (UNOS) shows that ... achieved the largest volumes and top-rated outcomes in ... among the top 20 heart transplant programs nationally. ...
... ovary removal is another reproductive factor linked to cardiovascular ... -- The things that affect a woman,s reproductive health ... research shows. , Giving birth prematurely or delivering a ... of cardiovascular disease in the mother, according to two ...
... 13 Stryker Corporation (NYSE: SYK ) announced today that ... that will be held:, April ... Radisson Plaza Hotel, ... both the audio and the video presentation from the meeting, is available ...
... In the ongoing effort to ensure physician and ... (ABMS) is convening consumer, legislative and purchaser stakeholders for ... ABMS is the not-for-profit organization that oversees U.S. ... at the forum are Janet M. Corrigan, PhD, MBA, ...
Cached Medicine News:Health News:Northwestern Memorial's Heart Transplant Program No. 1 in Illinois and Among Highest-Rated Nationally 2Health News:Northwestern Memorial's Heart Transplant Program No. 1 in Illinois and Among Highest-Rated Nationally 3Health News:Preemie Delivery Tied to Later Heart Woes for Women 2Health News:Preemie Delivery Tied to Later Heart Woes for Women 3Health News:Stryker to Provide Webcast and Telephone Access to Annual Shareholder Meeting 2Health News:ABMS Hosts First National Health Policy Forum to Address Physician Accountability and Health System Performance Standards 2Health News:ABMS Hosts First National Health Policy Forum to Address Physician Accountability and Health System Performance Standards 3
(Date:7/29/2014)... 29, 2014  Novation, a VHA and UHC ... breakthrough interactive features that automate key health care ... Children,s Hospital Association.  The new ... umbrella – Value Analysis, Item Master and Formulary ... address the most critical challenges brought on by ...
(Date:7/29/2014)... July 29, 2014  The BioFusionary Corporation, Inc. ... a proprietary electromagnetic induction platform with aesthetic and ... agreement under which TBC will merge with ... in an all-stock transaction. Upon completion ... on the Australian Stock Exchange under the code ...
(Date:7/29/2014)... -- Encision Inc. (OTCQB:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of $2.476 ... or $(0.02) per share. These results compare to net ... $311 thousand, or $(0.04) per share, in the year-ago ...
Breaking Medicine Technology:Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 2Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 3Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 4Breakthrough Novation Applications Empower Children's Hospital Association Members to Lower Costs, Increase Quality 5The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 2The BioFusionary Corporation, Inc. Announces Intent To Complete Reverse Takeover Of Australia-Based Continuation Investments Limited 3Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4
... , , , SAN FRANCISCO, Dec. 14 ... its promised announcement about health hazards of bisphenol A (BPA), ... harm and other illnesses, in time for Christmas. , ... Natural Resources Defense Council : "Just as you rely on ...
... ,Dec. 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. ... received a complete response letter from the U.S. Food ... Application ("NDA") for Onrigin(TM) (laromustine) injection submitted in February ... approve the Company,s NDA in its present form and ...
Cached Medicine Technology:Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3
... ACMI™ USA Elite System Rotating Continuous Flow ... the urologist to rotate the working element ... of the sheaths. The result no ... tangled tubing due to rotating flow ports, ...
... PC-based ECG device that can be ... an innovative software. The system enables ... using a standard 12-lead setup that ... software includes two applications: Rest ECG ...
Used for traversing and exploring urethral strictures. The malleable tip can be shaped to desired configuration. The proximal end is threaded to attach to standard followers. Supplied sterile in peel...
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: